Vemurafenib: First-in-Class BRAF-Mutated Inhibitor for the Treatment of Unresectable or Metastatic Melanoma. (Record no. 25576798)

MARC details
000 -LEADER
fixed length control field 00828 a2200205 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517071724.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201512s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2150-0878
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.6004/jadpro.2015.6.4.6
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Shelledy, Lindsay
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20151225
245 00 - TITLE STATEMENT
Title Vemurafenib: First-in-Class BRAF-Mutated Inhibitor for the Treatment of Unresectable or Metastatic Melanoma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of the advanced practitioner in oncology
Date of publication, distribution, etc.
300 ## - PHYSICAL DESCRIPTION
Extent 361-5 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Roman, Danielle
773 0# - HOST ITEM ENTRY
Title Journal of the advanced practitioner in oncology
Related parts vol. 6
-- no. 4
-- p. 361-5
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.6004/jadpro.2015.6.4.6">https://doi.org/10.6004/jadpro.2015.6.4.6</a>
Public note Available from publisher's website

No items available.